http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-2011026-I2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate | 2011-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NO-2011026-I2 |
titleOfInvention | Eribulin or a pharmaceutically acceptable salt thereof |
priorityDate | 1998-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134990500 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561839 |
Total number of triples: 16.